Most Recent
The terms of the Fair Work Act do not guarantee employees of Qantas or potentially any workers in Australia the right to entitlements such as annual leave for work done while receiving JobKeeper payments, the Full Federal Court has ruled.
The Full Federal Court has tossed an appeal by Treasury Wine Estates claiming that Maurice Blackburn and barrister Guy Donnellan breached their obligations in preparing the pleadings in a current shareholder class action against the global winemaker.
US-based consumer goods giant SC Johnson & Son has foreshadowed a bid to strike out a case filed by Reckitt Benckiser over its Raid Max insecticide ads after a Federal Court judge found Reckitt had a "weak" prima facie case.
Two patent attorneys who resigned from Pizzeys Patent and Trade Mark Attorneys to launch a competing business performed work for clients of the boutique IP firm a year after they jumped ship, in breach of their employment contracts, a lawsuit claims.
A judge has appointed a provisional liquidator to a company owned by missing Sydney businesswoman Melissa Caddick, while criticising ASIC for not cooperating with her brother who is seeking to vary asset preservation orders made over his sister's property.
The NSW government cannot assert public immunity over cabinet documents sought in a case brought by the ACCC over an allegedly anti-competitive agreement for the privatisation of Port Botany and Port Kembla.
Logistics services provider Qube has resolved a lawsuit that accused the Port of Newcastle of misusing its power in the market for port services by denying Qube's request to use its own equipment to provide dry bulk unloading services at the port.
Treasury Wine Estates has accused plaintiffs law firm Maurice Blackburn and barrister Guy Donnellan of "taking advantage" of their privileged position by using evidence discovered in a settled class action to file a second case against the wine maker.
Two psychiatrists at the heart of the Chelmsford deep sleep therapy scandal have had their defamation cases against publisher HarperCollins dismissed ,with a judge finding the lawsuits were an attempt to "rewrite history" regarding harm done to patients receiving their controversial treatment.
The High Court has declined to take up Mylan's challenge to a Full Court ruling upholding the invalidity of three patents for its blockbuster cholesterol drug Lipidil.